Elite Pharmaceuticals Inc (ELTP)

[RizZo]

Substance Abuse Treatment Market Projected to Gain Significant Value by 2024
August 7, 2020


Transparency Market Research (TMR) has published a new report titled, “Substance Abuse Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global substance abuse treatment market was valued at US$ 8,000 Mn in 2017. It is projected to expand at a CAGR of 8% from 2018 to 2026. The report suggests that emerging initiatives by manufacturers and governments and rise in abuse of prescription drugs are anticipated to boost the global substance abuse treatment market from 2018 to 2026. North America and Europe are expected to dominate the global substance abuse treatment market in the next few years, owing to market availability of new drugs and technology, rigorous research and development by major companies, and strong medical infrastructure. Players are continuously working in the global substance abuse treatment market. They also enter into distribution agreements to strengthen their presence across the globe. Key events in the market include submission of provisional patent application to the USPTO for proprietary pure cannabidiol compositions by Normaco in October 2018, approval of SUBLOCADE, by the FDA, launched in the U.S. in March 2018, and U.S. FDA approval for the ANDA for methadone hydrochloride (5 mg and 10 mg) tablets for Glenmark Pharmaceuticals and its strategic partner Elite Pharmaceuticals, Inc in August 2018.

https://researchnewspaper.com/substance-abuse-treatment-market-projected-to-gain-significant-value-by-2024/